QA: Biostax Corp. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001559356_2023_Biostax_Corp.pdf

Logs

Graph

Absolute values for 0001559356, Biostax Corp.

  xvar xval
0 AssetsCurrent 150,491
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 813,228
4 LiabilitiesCurrent 3,477,173
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,149,257
9 ResearchAndDevelopmentExpense 14,236
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -2,372,583
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 963,719
1 Liabilities 3,477,173
2 Expenses 1,163,493
3 Revenues 0
4 StockholdersEquity -2,513,454
5 NetIncome -3,536,076
6 ComprehensiveNetIncome -3,536,076
7 BaseVar 3,988,484
8 EconomicCapitalRatio -3.54

Edgar->Model Mapping

Feature Distribution

Change over Time